Greentech Chemi-Pharm Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 193.33%
- Profit Growth 427.07%
- Ebitda 167.74%
- Net Worth 15.97%
- Total Assets 14.59%
About Greentech Chemi-Pharm
Greentech Chemi-Pharm Private Limited (GCPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 September 2008 and has a history of 16 years and four months. Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Pravin Jagdale and Surjeet Ghorpade serve as directors at the Company.
Company Details
-
Location
Raigarh, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2008PTC187017
-
Company No.
187017
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Sep 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Greentech Chemi-Pharm?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravin Jagdale
|
Director | 10-Dec-2009 | Current |
|
Surjeet Ghorpade
|
Director | 10-Dec-2009 | Current |
Financial Performance of Greentech Chemi-Pharm.
Greentech Chemi-Pharm Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 193.33% increase. The company also saw a substantial improvement in profitability, with a 427.07% increase in profit. The company's net worth Soared by an impressive increase of 15.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greentech Chemi-Pharm?
In 2017, Greentech Chemi-Pharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Eurocel Chemical Industries Private LimitedPravin Jagdale and Surjeet Ghorpade are mutual person
-
Gajra Pride Hotels Private Limited
Pravin Jagdale is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Greentech Chemi-Pharm?
Unlock and access historical data on people associated with Greentech Chemi-Pharm, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greentech Chemi-Pharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greentech Chemi-Pharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
